Neuralink brain implant: Elon Musk's company looking for three patients for long term study. All you need to know

livemint.com:

Elon Musk, plans to enroll three patients in a study to evaluate its device, as per a Reuters report. The study, which is listed on the United States government's clinical trials database, is expected to take several years to complete.Originally, the company aimed to enroll 10 patients when it applied to US regulators to begin clinical trials, as reported by Reuters last year.

Neuralink's implant is designed to help paralyzed patients use digital devices through thought alone, potentially aiding those with spinal cord injuries.Also Read | Elon Musk's Brain Chip: User posts on X by 'thinking' after Neuralink implantNeuralink has received interest from potential patients for years, even before gaining approval to start human trials last year, Reuters reported citing sources.The study involves using a robot to surgically place a brain-computer interface (BCI) implant in the brain region that controls movement intention, as per a company statement.Neuralink's study is expected to have a primary completion date in 2026, with the full study ending in 2031. The study will involve patients aged 22 to 75 with conditions like quadriplegia.Also Read | Elon Musk's Neuralink responds to ‘Brain-Implant’ malfunction, implications for FDA approval and future trialsEligibility criteria require patients to have had limited mobility for at least one year and a life expectancy of at least 12 months.